Cliff Asness's BBNX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 308,468 shares of Beta Bionics, Inc. (BBNX) worth $4.83 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in BBNX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 248,181 shares. Largest reduction occurred in Q3 2025, reducing 3,423 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +248,181 | Add 411.67% | 308,468 | $15.67 |
| Q1 2026 | +9,882 | Add 19.61% | 60,287 | $10.02 |
| Q4 2025 | -1,605 | Reduce 3.09% | 50,405 | $30.47 |
| Q3 2025 | -3,423 | Reduce 6.18% | 52,010 | $19.87 |
| Q2 2025 | +55,433 | New Buy | 55,433 | $14.56 |
Cliff Asness's Beta Bionics Investment FAQs
Cliff Asness first purchased Beta Bionics, Inc. (BBNX) in Q2 2025, acquiring 55,433 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Beta Bionics, Inc. (BBNX) for 5 quarters since Q2 2025.
Cliff Asness's largest addition to Beta Bionics, Inc. (BBNX) was in Q2 2026, adding 308,468 shares worth $4.83 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 308,468 shares of Beta Bionics, Inc. (BBNX), valued at approximately $4.83 M.
As of the Q2 2026 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Beta Bionics, Inc. (BBNX) was 308,468 shares, as reported at the end of Q2 2026.